Vyant Bio, Inc.
USD0.19
+0.01 (+7.78%)
CEO
Andrew D.C. LaFrence CPA
IPO Date
2021-04-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.18
Prev. Close
$0.18
Day Low
$0.17
Day High
$0.20
52W Low
$0.14
52W High
$1.58
Volume
0.02M
| -0.7 |
| 31 Dec 2020 | FY | -27.0% | -1060.7% | 25.2% | -227.1% | -0.22 | 0.87 | -1.3 |
| 31 Dec 2019 | FY | 49.3% | -91.8% | -90.8% | -45.0% | 0.22 | 1.03 | -1.4 |
| 31 Dec 2018 | FY | 31.8% | -74.2% | -299.5% | -57.5% | 1.74 | 0.34 | -0.2 |
| 31 Dec 2017 | FY | 37.9% | -71.7% | -78.0% | -40.0% | 0.41 | 1.18 | -0.2 |
| 31 Dec 2016 | FY | 36.8% | -58.4% | -61.7% | -37.2% | 0.18 | 2.12 | -0.2 |
| 31 Dec 2015 | FY | 21.9% | -111.9% | -61.1% | -41.3% | 0.18 | 2.86 | -0.1 |
| 31 Dec 2014 | FY | 17.1% | -163.2% | -48.2% | -35.3% | 0.20 | 7.28 | -0.1 |
| 31 Dec 2013 | FY | 25.5% | -187.2% | -27.2% | -22.4% | 0.14 | 6.02 | -0.1 |
| -1.2 |
| 30 Jun 2022 | Q2 | -84.2% | -3511.5% | -34.5% | -21.6% | 0.13 | 2.16 | -1.2 |
| 31 Mar 2022 | Q1 | -27.4% | -3027.1% | -41.0% | -28.2% | 0.10 | 2.74 | -1.1 |
| 31 Dec 2021 | Q4 | 43.5% | 983.2% | -79.4% | -66.0% | 0.04 | 4.27 | -0.4 |
| 30 Sept 2021 | Q3 | 5.2% | -296.2% | -8.0% | -7.3% | 0.02 | 5.63 | -3.8 |
| 30 Jun 2021 | Q2 | 29.5% | -215.0% | -7.0% | -6.4% | 0.02 | 6.48 | -6.5 |
| 31 Mar 2021 | Q1 | -118.5% | -3318.0% | -11.5% | -10.2% | 0.02 | 4.69 | -0.5 |
| 31 Dec 2020 | Q4 | 9.1% | -888.3% | 6.5% | -58.1% | -0.22 | 0.87 | -1.4 |
| 30 Sept 2020 | Q3 | -12.5% | -892.5% | -62.2% | -30.9% | 0.04 | 0.59 | -1.3 |